Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease

Curr Med Sci. 2020 Dec;40(6):1022-1030. doi: 10.1007/s11596-020-2283-0. Epub 2021 Jan 11.

Abstract

Senile plaques (SPs) are one of the pathological features of Alzheimer's disease (AD) and they are formed by the overproduction and aggregation of amyloid-beta (Aβ) peptides derived from the abnormal cleavage of amyloid precursor protein (APP). Thus, understanding the regulatory mechanisms during Aβ metabolism is of great importance to elucidate AD pathogenesis. Recent studies have shown that epigenetic modulation-including DNA methylation, non-coding RNA alterations, and histone modifications-is of great significance in regulating Aβ metabolism. In this article, we review the aberrant epigenetic regulation of Aβ metabolism.

Keywords: Alzheimer’s disease; DNA methylation; amyloid-β; epigenetics; histone modifications; microRNAs.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism*
  • Amyloid beta-Peptides / metabolism*
  • Amyloid beta-Protein Precursor / metabolism*
  • DNA Methylation
  • Epigenesis, Genetic*
  • Histone Code
  • Humans
  • Protein Aggregates
  • RNA, Untranslated / genetics

Substances

  • APP protein, human
  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Protein Aggregates
  • RNA, Untranslated